VADUZ, Liechtenstein, 13 February 2023 – To comply with new stringent regulations enforced in Taiwan for the sale of medical device products, bonyf has received the TFDA (Taiwan Food and Drug Administration) approval for 2 core products.

bonyf was required to submit quality system documentation and undergo a rigorous audit from the TFDA for its Express Cleansing Denture Effervescent Tablet and Denture Adhesive Cream. After thorough investigation, approval was granted by the Taiwanese government allowing for sales expansion in the region. To commercialize products in Taiwan companies must comply with registration requirements of the TFDA. Pre-market approval is necessary for all classes of medical devices prior to Taiwanese market entry.

The TFDA approval in Taiwan is an important step for bonyf enabling further business expansion for the company.